scholarly article | Q13442814 |
P2093 | author name string | Mark A Brown | |
Julia J Spaan | |||
P2860 | cites work | Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin | Q24298747 |
A molecular variant of angiotensinogen associated with preeclampsia | Q24309422 | ||
The renin-aldosterone system during normal and hypertensive pregnancy | Q32015886 | ||
Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells | Q33586941 | ||
The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia | Q33591058 | ||
Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases | Q33677369 | ||
Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy | Q33893203 | ||
Increased renal α-epithelial sodium channel (ENAC) protein and increased ENAC activity in normal pregnancy | Q34305780 | ||
Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study | Q34341543 | ||
A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas | Q34577349 | ||
Elevated Plasma Chymotrypsin-like Protease (Chymase) Activity in Women with Preeclampsia | Q34707028 | ||
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses | Q34897462 | ||
Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
Angiotensin II receptor antagonist treatment during pregnancy | Q36019473 | ||
Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
Sodium-renin-aldosterone relations in normal and hypertensive pregnancy | Q36429185 | ||
Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
Contractility of placental vascular smooth muscle cells in response to stimuli produced by the placenta: roles of ACE vs. non-ACE and AT1 vs. AT2 in placental vessel cells | Q36915124 | ||
The relationship between aldosterone to renin ratio and RI value of the uterine artery in the preeclamptic patient vs. normal pregnancy | Q37040807 | ||
The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy | Q37328814 | ||
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
Angiotensin II levels in hypertensive and normotensive pregnancies | Q37664263 | ||
Renin in the female reproductive system | Q39612855 | ||
Regulation of placental growth by aldosterone and cortisol | Q39633468 | ||
Stimulating autoantibodies against the angiotensin II type 1 receptor are not associated with preeclampsia in Mexican-Mestizo women | Q39742365 | ||
Control of vascular responsiveness during human pregnancy | Q40122647 | ||
The effects of intravenous angiotensin II upon blood pressure and sodium and urate excretion in human pregnancy | Q41440981 | ||
The renin-angiotensin-aldosterone system in pre-eclampsia | Q41554361 | ||
Sodium excretion in normal and hypertensive pregnancy: a prospective study | Q41976105 | ||
Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation | Q43912171 | ||
Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation | Q44218760 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy | Q44676306 | ||
Evidence for compromised aldosterone synthase enzyme activity in preeclampsia | Q45166218 | ||
Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in rats | Q46815759 | ||
Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction | Q46870238 | ||
Raised prorenin and renin concentrations in pre-eclamptic placentae when measured after acid activation | Q47354701 | ||
Placental angiotensin II receptor AT1R in normotensive patients and its correlation between infant birth weight. | Q47447905 | ||
The human placental renin-angiotensin system | Q48430627 | ||
Extracellular fluid volumes in pregnancy-induced hypertension | Q50798261 | ||
Markers of cardiovascular disease risk after hypertension in pregnancy. | Q51363791 | ||
Maternal protein restriction reduces angiotensin II AT(1) and AT(2) receptor expression in the fetal rat kidney. | Q51904900 | ||
Immunology in hypertension, preeclampsia, and target-organ damage. | Q52909791 | ||
Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. | Q52933863 | ||
Aldosterone excretion in normal and toxaemic pregnancies. | Q55510105 | ||
Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor | Q56963444 | ||
Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II | Q58223924 | ||
Atrial Natriuretic Peptide and Plasma Volume in Pregnancy-Induced Hypertension | Q67906726 | ||
Renin-aldosterone relationships in pregnancy-induced hypertension | Q68044331 | ||
Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia | Q68432345 | ||
Stimulation of active renin release in normal and hypertensive pregnancy | Q68487621 | ||
A renin-like substance in the human placenta | Q68564317 | ||
Uteroplacental unit as a source of elevated circulating prorenin levels in normal pregnancy | Q68921259 | ||
Impaired renin stimulation in pre-eclampsia | Q72066075 | ||
Role of renin-angiotensin system in blood pressure regulation in pregnancy | Q72135618 | ||
Angiotensin-II stimulates estradiol secretion from human placental explants through AT1 receptor activation | Q72149716 | ||
Stimulation of aldosterone by ACTH in normal and hypertensive pregnancy | Q72343170 | ||
Angiotensin II induces human placental lactogen and pregnancy-specific beta 1-glycoprotein secretion via an angiotensin AT1 receptor | Q72798082 | ||
Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies | Q72818462 | ||
Role for endothelin-1 in angiotensin II-mediated hypertension | Q73532048 | ||
Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells | Q74188076 | ||
Prorenin concentration in the hypertensive disorders in pregnancy | Q74226788 | ||
PLASMA-RENIN IN NORMALPREGNANCY | Q76513578 | ||
Human spiral artery renin-angiotensin system | Q77418886 | ||
The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy | Q78039553 | ||
Angiotensin-(1-7) in normal and preeclamptic pregnancy | Q78568866 | ||
Pressor response to angiotonin in pregnant and nonpregnant women | Q78762451 | ||
Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension? | Q81335103 | ||
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
Maternal/newborn genotype contribution of the renin-angiotensin system (Met235Thr, Thr174Met, I/D-ACE, A2350G-ACE, A1166C-AT2R1, C3123A- AT2R2, 83A/G-REN) to the risk of pre-eclampsia: a Romanian study | Q83706578 | ||
Molecular evidence of a (pro)renin/ (pro)renin receptor system in human intrauterine tissues in pregnancy and its association with PGHS-2 | Q84723355 | ||
Does prorenin exert angiotensin-independent effects in vivo? | Q84749465 | ||
Detrimental effects of dual ACEI-ARB therapy: is the (pro)renin receptor the culprit? | Q85092503 | ||
Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy | Q93732540 | ||
P433 | issue | 4 | |
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | 147-153 | |
P577 | publication date | 2012-12-06 | |
P1433 | published in | Obstetric medicine | Q26842307 |
P1476 | title | Renin-angiotensin system in pre-eclampsia: everything old is new again. | |
P478 | volume | 5 |
Q99711916 | Plane-Wave Ultrasound Doppler of the Eye in Preeclampsia | cites work | P2860 |
Search more.